Instil Bio (TIL) Non Operating Income (2020 - 2025)
Instil Bio (TIL) posted quarterly Non Operating Income of -$55000.0 for Q4 2025, up 95.41% year-over-year from -$28146.1 in Q4 2024, and up 53.39% quarter-over-quarter from -$118000.0 in Q3 2025.
Instil Bio (TIL) Non Operating Income (2020 - 2025) Analysis & Trends
Instil Bio's Non Operating Income history runs 6 years deep, the most recent figure standing at -$55000.0 for Q4 2025.
- In Q4 2025, Non Operating Income rose 95.41% year-over-year to -$55000.0; the TTM figure through Dec 2025 stood at $212000.0 (up 107.42% YoY), while the FY2025 annual figure was $212000.0, up 107.42% from the prior year.
- Non Operating Income for Q4 2025 stood at -$55000.0, up from -$118000.0 in the prior quarter.
- The five-year high for Non Operating Income was $1.3 million in Q4 2022, with the low at -$1.2 million in Q4 2024.
- The 5-year median for Non Operating Income is -$267500.0 (2022), against an average of -$252600.0.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income surged 326.7% in 2022, then sank 898.33% in 2024.
- Instil Bio's Non Operating Income stood at -$573000.0 in 2021, then soared by 326.7% to $1.3 million in 2022, then sank by 109.24% to -$120000.0 in 2023, then tumbled by 898.33% to -$1.2 million in 2024, then surged by 95.41% to -$55000.0 in 2025.
- Business Quant data shows TIL's Non Operating Income at -$55000.0 in Q4 2025, -$118000.0 in Q3 2025, and $342000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -55,000.00 |
| Sep 30, 2025 | -118,000.00 |
| Jun 30, 2025 | 342,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -530,000.00 |
| Jun 30, 2024 | -702,000.00 |
| Mar 31, 2024 | -428,000.00 |
| Dec 31, 2023 | -120,000.00 |
| Sep 30, 2023 | -1.03 Mn |
| Jun 30, 2023 | 628,000.00 |
| Mar 31, 2023 | -57,000.00 |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | -415,000.00 |
| Jun 30, 2022 | -1.03 Mn |
| Mar 31, 2022 | -416,000.00 |
| Dec 31, 2021 | -573,000.00 |
| Sep 30, 2021 | -661,000.00 |
| Jun 30, 2021 | -104,000.00 |
| Mar 31, 2021 | 71,000.00 |